Sepsis — Clinical Documentation Guide (2026)

🔍 1. Definition

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. The modern Sepsis-3 consensus definition, published in JAMA (2016) and reinforced by the 2026 Surviving Sepsis Campaign (SSC) Guidelines, defines sepsis as suspected or confirmed infection plus acute organ dysfunction, operationalized as a Sequential Organ Failure Assessment (SOFA) score increase of ≥ 2 points from baseline.

Septic shock is a subset of sepsis with profound circulatory, cellular, and metabolic abnormalities: vasopressor requirement to maintain mean arterial pressure (MAP) ≥ 65 mmHg and serum lactate > 2 mmol/L (18 mg/dL) despite adequate fluid resuscitation, associated with in-hospital mortality exceeding 40%.

For ICD-10-CM coding and CMS reimbursement purposes, facilities continue to apply the older Sepsis-2/SIRS framework alongside Sepsis-3 because the ICD-10-CM FY2026 Official Guidelines (Section I.C.1.d) and the code set itself still reference systemic inflammatory response syndrome (SIRS), severe sepsis (R65.20/R65.21), and septic shock terminology. Documentation must explicitly state sepsis — SIRS criteria alone are insufficient for code assignment per guideline I.A.19.

🗂️ 2. Alternative Terminology

The clinical and documentation landscape for sepsis includes multiple synonymous, near-synonymous, and outdated terms. Understanding these is critical for CDI and coders who must reconcile physician notes, nursing documentation, and discharge summaries.

🩺 3. Signs & Symptoms

Sepsis presents with a spectrum of findings reflecting the underlying infection and the systemic inflammatory response. The qSOFA (quick SOFA) score provides a rapid bedside screening tool, while the full SOFA score quantifies organ dysfunction.

qSOFA criteria (1 point each; score ≥ 2 suggests poor outcome in infection):

• Respiratory rate ≥ 22 breaths/minute
• Systolic blood pressure ≤ 100 mmHg
• Altered mental status (GCS < 15)

Additional clinical signs often documented:

• Fever (> 38.3°C / 101°F) or hypothermia (< 36°C / 96.8°F)
• Tachycardia (heart rate > 90 bpm)
• Leukocytosis (WBC > 12,000/μL) or leukopenia (WBC < 4,000/μL)
• Elevated serum lactate (> 2 mmol/L indicates tissue hypoperfusion)
• Hypotension (MAP < 65 mmHg) — hallmark of septic shock
• Oliguria (urine output < 0.5 mL/kg/hr for > 2 hours)
• Elevated creatinine, bilirubin, or coagulation abnormalities
• Thrombocytopenia (platelets < 100,000/μL)
• Decreased capillary refill, mottling, cold extremities

SOFA score organ systems (score 0–4 per system; ≥ 2-point increase = organ dysfunction):

🧭 4. Differential Diagnosis

Several conditions mimic sepsis or can present simultaneously with sepsis, creating documentation and coding challenges. CDI specialists should ensure that the principal diagnosis is clearly documented as sepsis when it meets the definition, not a mimicking condition.

📋 5. Clinical Indicators for Coders/CDI

CDI specialists should scan for the following clinical indicators in the medical record to identify potential documentation gaps and trigger appropriate queries before final coding.

🦴 6. Anatomy & Pathophysiology

Sepsis arises when a localized infection overwhelms host containment mechanisms, triggering a systemic cascade. The pathophysiology involves three interconnected processes:

1. Infection and Pattern Recognition: Bacterial, fungal, viral, or parasitic pathogens release pathogen-associated molecular patterns (PAMPs — e.g., lipopolysaccharide, peptidoglycan) recognized by innate immune receptors (TLR-4 for LPS). Host cell damage releases damage-associated molecular patterns (DAMPs). This activates macrophages, neutrophils, and endothelial cells.

2. Dysregulated Inflammatory Response: Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) are released, triggering systemic vasodilation, increased vascular permeability, and coagulation activation. In sepsis, this response is excessive and maladaptive — the host response causes collateral damage to organs. Simultaneously, anti-inflammatory cytokines (IL-10) lead to immune suppression and immunoparalysis, increasing susceptibility to secondary infections.

3. Microvascular Dysfunction and Organ Failure: Endothelial injury leads to capillary leak, third-spacing of fluids, and distributive shock. Microthrombi from coagulopathy compromise end-organ perfusion. Mitochondrial dysfunction impairs cellular oxygen utilization (cytopathic hypoxia). Organs fail in a progressive cascade: lungs (ARDS), kidneys (AKI), liver (hepatic dysfunction), brain (septic encephalopathy), and coagulation system (DIC).

The lung is typically the first organ to fail, presenting as acute respiratory distress syndrome (ARDS), coded as J80 and representing an important organ dysfunction code when documenting severe sepsis.

💊 7. Medication Impact / Treatment

The 2026 Surviving Sepsis Campaign Guidelines outline evidence-based pharmacologic interventions with direct coding and documentation implications:

Antimicrobials: For septic shock or probable/definite sepsis, guidelines recommend administration within 1 hour of recognition (strong recommendation). For possible sepsis without shock, within 3 hours. Early, appropriate antibiotic therapy must be documented to support the diagnosis in coding. The specific antimicrobial used supports organism-specific coding (e.g., vancomycin/linezolid suggests MRSA; piperacillin-tazobactam suggests gram-negative coverage).

Vasopressors: Norepinephrine is first-line vasopressor in septic shock (strong recommendation per 2026 SSC). Vasopressin may be added for escalating norepinephrine doses. The use of vasopressors is a key clinical indicator for septic shock documentation. Norepinephrine is billed under HCPCS J3490 (unclassified drug, no dedicated J-code for generic norepinephrine bitartrate in most formularies) or facility-specific drug codes.

Corticosteroids: IV hydrocortisone 200–300 mg/day is recommended in septic shock unresponsive to adequate fluid/vasopressor therapy. Steroid use does not independently affect sepsis coding but should be noted in the patient record as evidence of refractory septic shock.

Fluid Resuscitation: At least 30 mL/kg IV crystalloid (balanced crystalloids preferred over normal saline per 2026 SSC) in the first 3 hours. Albumin may be appropriate after large crystalloid volumes. Avoiding hydroxyethyl starch (strongly recommended against). Fluid administration is part of the sepsis order set and supports clinical indicator documentation.

Insulin Therapy: Glucose management targeting < 180 mg/dL in ICU patients with sepsis. When insulin drip is initiated, document hyperglycemia or diabetes as comorbidity codes.

Mechanical Ventilation (Lung Protective): For ARDS complicating sepsis: tidal volume 6 mL/kg predicted body weight, plateau pressure ≤ 30 cmH₂O. CPT codes 94002–94003 apply for initiation of invasive ventilation; duration determines DRG (870 if > 96 hours continuous).

Documentation Alert — Drug Therapy Links to Organ Dysfunction: Vasopressor initiation → document septic shock (R65.21). Mechanical ventilation → document acute respiratory failure (J96.0x) and if > 96 hrs consider DRG 870. Renal replacement therapy → document acute kidney injury (N17.x) as organ dysfunction under severe sepsis.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO CDG members.